ArticleAdvances in medical education and practice2026
Allergology Specialty Development and Talent Cultivation in China (2022-2025).
Article in Advances in medical education and practice, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: To analyze the status of allergology specialty development across seven regions of China from 2022 to 2025, evaluating institutional scale, workforce, service capacity, and regional equity, and to compare with international levels. Methods: Two national cross-sectional surveys were conducted in 2022 and 2025, covering 502 and 520 hospitals, respectively, across all 31 provinces (seven regions) of mainland China, using the same structured questionnaire. Of these, 87 hospitals (2022) and 139 hospitals (2025) with independent allergology departments were identified as the primary analytical sample. Descriptive statistics with 95% confidence intervals (Wilson method), the population-weighted Gini coefficient, and the coefficient of variation were used to assess development trends and regional disparities. Results: Independent allergology departments increased from 87 to 139 (+59.8%), and allergists from 371 to 770 (+107.5%), while the growth rates of nurses (+62.3%) and technicians (+44.8%) were considerably lower than that of physicians. Resources were concentrated in East and North China, which together accounted for 46.8% of departments and 56.8% of physicians. The national tertiary hospital coverage rate was 3.4% (95% CI 2.9-4.0), ranging from 5.8% in Northeast China to 1.1% in Southwest China. The physician-to-nurse ratio was 1:0.68, and the physician-to-technician ratio was 1:0.31. Technical readiness reached 82.7% (93.9% in East vs. 50.0% in Southwest). Master's or doctoral programs were available in 27.3% of departments. Discussion: China's allergology specialty has grown rapidly in department numbers and workforce size, yet marked regional disparities persist. The low tertiary hospital coverage (3.4%), the decline in the proportion of departments with master's or doctoral programs (33.3% to 27.3%), and an allergist density far below European levels (approximately 0.055 vs. 1.81 per 100,000 population) highlight the need for regionally tailored workforce planning, expanded tertiary hospital coverage in underserved regions, and strengthened local training capacity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.